Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP647017.RA1uKvC7gFHS5uAq3HvThgBN_tYmgTuiBG4ukpVBHdOU0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP647017.RA1uKvC7gFHS5uAq3HvThgBN_tYmgTuiBG4ukpVBHdOU0130_assertion type Assertion NP647017.RA1uKvC7gFHS5uAq3HvThgBN_tYmgTuiBG4ukpVBHdOU0130_head.
- NP647017.RA1uKvC7gFHS5uAq3HvThgBN_tYmgTuiBG4ukpVBHdOU0130_assertion description "[Furthermore, asymptomatic carriers with the ALK1 mutation within the serine - threonine kinase domain are at risk of developing PAH and hereditary hemorrhagic telangiectasia, so close follow-up is recommended for those individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP647017.RA1uKvC7gFHS5uAq3HvThgBN_tYmgTuiBG4ukpVBHdOU0130_provenance.
- NP647017.RA1uKvC7gFHS5uAq3HvThgBN_tYmgTuiBG4ukpVBHdOU0130_assertion evidence source_evidence_literature NP647017.RA1uKvC7gFHS5uAq3HvThgBN_tYmgTuiBG4ukpVBHdOU0130_provenance.
- NP647017.RA1uKvC7gFHS5uAq3HvThgBN_tYmgTuiBG4ukpVBHdOU0130_assertion SIO_000772 18159113 NP647017.RA1uKvC7gFHS5uAq3HvThgBN_tYmgTuiBG4ukpVBHdOU0130_provenance.
- NP647017.RA1uKvC7gFHS5uAq3HvThgBN_tYmgTuiBG4ukpVBHdOU0130_assertion wasDerivedFrom befree-2016 NP647017.RA1uKvC7gFHS5uAq3HvThgBN_tYmgTuiBG4ukpVBHdOU0130_provenance.
- NP647017.RA1uKvC7gFHS5uAq3HvThgBN_tYmgTuiBG4ukpVBHdOU0130_assertion wasGeneratedBy ECO_0000203 NP647017.RA1uKvC7gFHS5uAq3HvThgBN_tYmgTuiBG4ukpVBHdOU0130_provenance.